Our Approach:

Barricade Therapeutics, Corp. is a privately held biotech company based in Dallas – Fort Worth, TX. Barricade was founded based on discovery and advancement of novel first-in-class small molecules, by integrating complex molecule synthesis, chemistry, and molecular pharmacology with targeted therapeutic approaches in cancer biology. The company is focused on the development of uniquely innovative targeted drugs for the treatment of patients with cancer.

Meet the Team:

Neil Thapar

Neil Thapar, PharmD

CEO & Chief Scientific Officer


Melissa Krauth, MBA

Chief Business Officer


John Walling, PhD

Chief Operating Officer

Scientific Advisory Board:


Jef K. Brabander, PhD


Deepak Nijhawan, MD, PhD


Sunil Sharma, MD, FACP, MBA